Not applicableStudy completedNCT00579215What this trial is testingLung Cancer Informational Study (LCIS)Who this might be right forCancerEnhanced CareDecision-Making+3 more Memorial Sloan Kettering Cancer Center 8
Large-scale testing (Phase 3)Looking for participantsNCT06096844What this trial is testingChemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialWho this might be right forAdvanced Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more National Cancer Institute (NCI) 304
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664What this trial is testingTrametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally AdvancedWho this might be right forMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012254What this trial is testingNivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain MetastasesWho this might be right forNon Small Cell Lung CancerBrain Metastases, AdultLung Cancer Fundación GECP 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647What this trial is testingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forLung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more SWOG Cancer Research Network 116
Not applicableLooking for participantsNCT04151940What this trial is testingPET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung CancerWho this might be right forMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8 University of Washington 80
Not applicableEnded earlyNCT05407038What this trial is testingRemote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related FatigueWho this might be right forAdvanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more Mayo Clinic 7
Not applicableStudy completedNCT04229381What this trial is testingResiliency Among Older Adults Receiving Lung Cancer TreatmentWho this might be right forAdvanced Lung CarcinomaExtensive Stage Lung Small Cell CarcinomaStage IIIA Lung Cancer AJCC v8+6 more Ohio State University Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600701What this trial is testingAtezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung CancerWho this might be right forMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaRefractory Lung Non-Small Cell Carcinoma+1 more National Cancer Institute (NCI) 51
Large-scale testing (Phase 3)Active Not RecruitingNCT03793179What this trial is testingTesting the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerWho this might be right forLung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more National Cancer Institute (NCI) 600
Early research (Phase 1)Active Not RecruitingNCT04007744What this trial is testingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more Mayo Clinic 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Large-scale testing (Phase 3)Looking for participantsNCT04181060What this trial is testingOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerWho this might be right forAdvanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+2 more National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Ended earlyNCT04789668What this trial is testingBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT05025748What this trial is testingAsk Questions (ASQ):Implementation of a Communication InterventionWho this might be right forStage II Breast CancerStage III Breast CancerStage IV Breast Cancer+20 more Barbara Ann Karmanos Cancer Institute 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017025What this trial is testingAurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerWho this might be right forAdvanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more M.D. Anderson Cancer Center 32
Early research (Phase 1)Looking for participantsNCT05098210What this trial is testingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT04902040What this trial is testingPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesWho this might be right forAdvanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07288034What this trial is testingImmunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialWho this might be right forLung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8 City of Hope Medical Center 535
Testing effectiveness (Phase 2)Study completedNCT01004731What this trial is testingStudy of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerWho this might be right forStage IV Non-Small Cell Lung Cancer University of Alabama at Birmingham 7